Le Lézard
Classified in: Health
Subjects: SVY, REL

1.37 MILLION JEWISH ADULTS AND CHILDREN LIVE IN EIGHT-COUNTY NEW YORK AREA


NEW YORK, May 9, 2024 /PRNewswire/ -- The eight-county New York area continues to be home to the greatest concentration of Jewish people of any metropolitan area in the United States, according to UJA-Federation of New York's Jewish Community Study of New York 2023. Released today, the study, is based on nearly 6,000 questionnaires that were completed during the spring of 2023. The study examines and reports on community size, demographics, poverty, mental health, Jewish ritual observance, and participation in Jewish programs.

"The 2023 Jewish Community Study of New York offers a comprehensive snapshot of our community. Particularly in this challenging moment, these insights will help guide funding decisions so we can reach people where they are and ensure the strength of our Jewish community and the institutions serving them," said Eric S. Goldstein, CEO, UJA-Federation of New York.

In the report, UJA does not make direct comparisons about the change in Jewish population from 2011 ? the year of the last New York Jewish population study ? to 2023 because of methodological differences between the two studies, including mode differences in how the two surveys were conducted (telephone interviews compared to web-based surveys), survey identification processes, and weighting procedures. As a result, when considering the change in the population over time, the 2023 study presents a historical view (looking back to studies in both 1991 and 2002) to provide long-term population trends. Over the past three decades, the New York area has experienced broad stability in the total number of Jewish adults and children in the eight-county area, with the Jewish population hovering around 1.4 million people.

Key findings:

Total Jewish Population:


Jewish Adults

Jewish Children

Jewish People

Bronx

29,000

4,000

33,000

Brooklyn

305,000

157,000

462,000

Manhattan

237,000

40,000

277,000

Queens

126,000

23,000

150,000

Staten Island

35,000

2,000

38,000

Subtotal

732,000

227,000

960,000

Nassau

177,000

45,000

222,000

Suffolk

77,000

7,000

85,000

Westchester

88,000

16,000

105,000

Subtotal

343,000

68,000

412,000

Total

1,076,000

296,000

1,372,000

 

Poverty

Denomination

Demographics

The U.S. Census is prohibited from asking questions about religion, so the 2023 Jewish Community Study of New York is the prime source of information about the Jewish community in the current moment. The survey collected data from a cross-sectional, representative sample of New York-area adults who live in a Jewish household. The geographic scope is the New York eight-county area ? the five New York City boroughs, Nassau, Suffolk, and Westchester counties.

A complete methodological report can be found online at: https://communitystudy.ujafedny.org/methodology. UJA-Federation contracted with the research firm SSRS to design this study and collect the data. The margin of error for the entire sample of adults in Jewish households is ± 1.5 percentage points.

SOURCE UJA-Federation of New York


These press releases may also interest you

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...



News published on and distributed by: